On November 5, 2024 UroGen Pharma Ltd. (Nasdaq:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that management will participate in a fireside chat at the Guggenheim Securities Healthcare Innovation Conference to take place November 11-13, 2024 (Press release, UroGen Pharma, NOV 5, 2024, View Source [SID1234647746]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Securities Healthcare Innovation Conference

Date / Time:

November 12, 2024 at 3:00 PM ET

Format:

Fireside Chat and 1×1 investor meetings

Location:

Boston, MA

Webcast Link:

here

A live public webcast from the conference will also be available on UroGen’s Investor Relations website. A replay will be available on the site for approximately 90 days.